166 related articles for article (PubMed ID: 8303624)
1. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.
Dahlén B; Margolskee DJ; Zetterström O; Dahlén SE
Thorax; 1993 Dec; 48(12):1205-10. PubMed ID: 8303624
[TBL] [Abstract][Full Text] [Related]
2. Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.
Gaddy JN; Margolskee DJ; Bush RK; Williams VC; Busse WW
Am Rev Respir Dis; 1992 Aug; 146(2):358-63. PubMed ID: 1489125
[TBL] [Abstract][Full Text] [Related]
3. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.
Dahlén B; Kumlin M; Margolskee DJ; Larsson C; Blomqvist H; Williams VC; Zetterström O; Dahlén SE
Eur Respir J; 1993 Jul; 6(7):1018-26. PubMed ID: 8396534
[TBL] [Abstract][Full Text] [Related]
4. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
5. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
Dahlén B; Nizankowska E; Szczeklik A; Zetterström O; Bochenek G; Kumlin M; Mastalerz L; Pinis G; Swanson LJ; Boodhoo TI; Wright S; Dubé LM; Dahlén SE
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738
[TBL] [Abstract][Full Text] [Related]
6. Bronchodilator properties of an inhaled leukotriene D4 antagonist (verlukast--MK-0679) in asthmatic patients.
Lammers JW; Van Daele P; Van den Elshout FM; Decramer M; Buntinx A; De Lepeleire I; Friedman B
Pulm Pharmacol; 1992 Jun; 5(2):121-5. PubMed ID: 1611229
[TBL] [Abstract][Full Text] [Related]
7. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.
Kips JC; Joos GF; De Lepeleire I; Margolskee DJ; Buntinx A; Pauwels RA; Van der Straeten ME
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):617-21. PubMed ID: 1892302
[TBL] [Abstract][Full Text] [Related]
8. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
[TBL] [Abstract][Full Text] [Related]
9. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma.
Christie PE; Smith CM; Lee TH
Am Rev Respir Dis; 1991 Oct; 144(4):957-8. PubMed ID: 1928974
[TBL] [Abstract][Full Text] [Related]
10. Airway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects.
Christie PE; Schmitz-Schumann M; Spur BW; Lee TH
Eur Respir J; 1993 Nov; 6(10):1468-73. PubMed ID: 8112440
[TBL] [Abstract][Full Text] [Related]
11. Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids.
Reiss TF; Sorkness CA; Stricker W; Botto A; Busse WW; Kundu S; Zhang J
Thorax; 1997 Jan; 52(1):45-8. PubMed ID: 9039239
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
Hamilton AL; Watson RM; Wyile G; O'Byrne PM
Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518
[TBL] [Abstract][Full Text] [Related]
13. Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679.
Impens N; Reiss TF; Teahan JA; Desmet M; Rossing TH; Shingo S; Zhang J; Schandevyl W; Verbesselt R; Dupont AG
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1442-6. PubMed ID: 8389106
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
Manning PJ; Watson RM; Margolskee DJ; Williams VC; Schwartz JI; O'Byrne PM
N Engl J Med; 1990 Dec; 323(25):1736-9. PubMed ID: 2174121
[TBL] [Abstract][Full Text] [Related]
15. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
Margolskee DJ
Ann N Y Acad Sci; 1991; 629():148-56. PubMed ID: 1659276
[No Abstract] [Full Text] [Related]
17. Development of novel leukotriene--based anti-asthma drugs: MK-886 and MK-571.
Young RN
Agents Actions Suppl; 1991; 34():179-87. PubMed ID: 1793062
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist.
Mastalerz L; Nizankowska E; Sanak M; Mejza F; Pierzchalska M; Bazan-Socha S; Bestynska-Krypel A; Cmiel A; Szczeklik A
Eur J Clin Invest; 2002 Dec; 32(12):949-55. PubMed ID: 12534456
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
[TBL] [Abstract][Full Text] [Related]
20. Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma.
Wahedna I; Wisniewski AS; Tattersfield AE
Br J Clin Pharmacol; 1991 Oct; 32(4):512-5. PubMed ID: 1958449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]